A Randomized-Control Study of Gym Tonic's Community Based Strength Training Intervention.

December 3, 2020 updated by: PulseSync Pte Ltd

A Randomized-Control Study of Gym Tonic's Community Based Strength Training Intervention on Physical Function and Frailty Reversal, for Elderly Singaporeans.

Launched in April 2015 , Gym Tonic is the first of its kind cross-border exercise-as-medicine partnership between research institutions, business enterprises and service providers from Singapore and Finland. What sets Gym Tonic apart from other exercise programmes is its singular focus on strength training, necessary for frailty prevention and maintenance of functional independence for the elderly.

This randomized-control trial is to validate the Gym Tonic programme and data as well measuring its effectiveness in improving physical functions and reversing frailty.

Study Overview

Status

Completed

Detailed Description

The RCT is conducted in 3 eldercare community centers. In each center, a group of elderly will be randomly sorted into 2 groups. An intervention group and a control group.

The intervention group will go through 12 weeks of Gym Tonic progressive training programme. While the control group acts as a control. After the first 12 weeks, the intervention group will be going through another 12 weeks of Gym Tonic maintenance programme, while the control group will be going through the Gym Tonic progressive training programme.

Measurements of physical functions, isometric strength and frailty will be conducted pre trial, post 12 weeks and post 24 weeks.

Study Type

Interventional

Enrollment (Actual)

318

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore, 339511
        • PulseSync

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged 65 years and above
  • Pre-frail or mildly frail, as measured by the 5 CHS criteria of physical frailty: unintentional weight loss, slowness, weakness, exhaustion, low activity level or FRAIL
  • Able to ambulate without personal assistance
  • Enrolled into the 3 sites above

Exclusion Criteria:

  • Bedbound
  • Terminally ill patients with life expectancy <12 months
  • Significant cognitive impairment
  • Major depression
  • Wear pacemaker
  • Severe audiovisual impairment
  • Any progressive, degenerative neurologic disease
  • Participating in other interventional studies
  • Unavailable to participate for the full duration of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: GT
12 weeks of progressive training in the first phase and 12 weeks of maintenance training in the second phase.
12 week progressive training - Strength exercises on 6 pneumatic gym equipment following Gym Tonic's protocol twice a week 12 weeks maintenance training - Strength exercises on 6 pneumatic gym equipment following Gym Tonic's protocol once a week
Other: Control

No intervention for the first phase and will be active comparator in the second phase.

No intervention for the first 12 weeks (first phase) and 12 weeks of progressive training in the second phase.

12 week progressive training - Strength exercises on 6 pneumatic gym equipment following Gym Tonic's protocol twice a week 12 weeks maintenance training - Strength exercises on 6 pneumatic gym equipment following Gym Tonic's protocol once a week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Isometric Muscle Strength (Knee Extension)
Time Frame: week 0, week 12, week 24
Measured via isometric performance recorder fixed to exercise machine for the right and left leg.
week 0, week 12, week 24
Change in Isometric Muscle Strength (Knee Flexion)
Time Frame: week 0, week 12, week 24
Measured via isometric performance recorder fixed to exercise machine for the right and left leg.
week 0, week 12, week 24
Change in Isometric Muscle Strength (Hip Abduction)
Time Frame: week 0, week 12, week 24
Measured via isometric performance recorder fixed to exercise machine for the above mentioned movement.
week 0, week 12, week 24
Change in Isometric Muscle Strength (Hip Adduction)
Time Frame: week 0, week 12, week 24
Measured via isometric performance recorder fixed to exercise machine for the above mentioned movement.
week 0, week 12, week 24
Handgrip Strength
Time Frame: week 0, week 12, week 24

Subject will be seated, with the arm unsupported, elbow joint at 90 degrees and wrist in a neutral position while holding the hand dynamometer.

Subject would be required to squeeze the grip with maximum strength upon command for three attempts. The best result would be recorded.

week 0, week 12, week 24
SPPB Balance Test - Feet together (side-by-side)
Time Frame: week 0, week 12, week 24

To balance in the said position for 10 seconds.

Scored point will be determined by number of seconds held.

week 0, week 12, week 24
SPPB Balance Test - Semi-Tandem stand
Time Frame: week 0, week 12, week 24

To balance in the said position for 10 seconds.

Scored point will be determined by number of seconds held.

week 0, week 12, week 24
SPPB Balance Test - Tandem stand
Time Frame: week 0, week 12, week 24

To balance in the said position for 10 seconds.

Scored point will be determined by number of seconds held.

week 0, week 12, week 24
SPPB 5 times sit-to-stand
Time Frame: week 0, week 12, week 24

Seated with arms folded across chest and with their back against the chair, Stand up fully and sit down fully with the back against the chair as quickly as possible.

Scored point will be determined by the time to completely finish 5 repetitions.

week 0, week 12, week 24
SPPB Speed Walk Test (Normal)
Time Frame: week 0, week 12, week 24
To walk 4 metres at participant's usual speed, scored point will be determined based on time taken to complete the 4-Metre walk.
week 0, week 12, week 24
SPPB Speed Walk Test (Fast)
Time Frame: week 0, week 12, week 24
To walk 4 metres at participant's fastest speed, scored point will be determined based on time taken to complete the 4-Metre walk.
week 0, week 12, week 24

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 10, 2018

Primary Completion (Actual)

July 19, 2019

Study Completion (Actual)

October 15, 2019

Study Registration Dates

First Submitted

November 19, 2020

First Submitted That Met QC Criteria

December 3, 2020

First Posted (Actual)

December 10, 2020

Study Record Updates

Last Update Posted (Actual)

December 10, 2020

Last Update Submitted That Met QC Criteria

December 3, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty

Clinical Trials on Gym Tonic programme and Gym equipment

Subscribe